# Nanobac Pharmaceuticals, Incorporated (NNBP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NNBP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2007 | $ 26.7K | $ -9.96M | $ -1.38M | $ 4.12M | $ -2.36M |
| 2006 | $ 340.8K | $ -7.53M | $ -3.93M | $ 5.37M | $ -1.31M |
| 2005 | $ 994.5K | $ -5.01M | $ -3.64M | $ 2.49M | $ 2.46M |
| 2004 | $ 542.6K | $ -11.92M | $ -5.20M | $ 256.4K | $ 6.11M |
| 2003 | $ 731.1K | $ -4.82M | $ -3.12M | $ 5.73M | $ -806.2K |
| 2000 | $ 3.34M | $ -2.90M | $ 222.9K | $ 4.59M | $ -7.06M |
| 1999 | $ 4.72M | $ -2.72M | $ 50.2K | $ 4.70M | $ -5.19M |
| 1997 | $ 3.94M | $ -454.2K | $ 0 | $ 6.70M | $ -2.40M |
| 1996 | $ 13.44M | $ -1.88M | $ -44.5K | $ 6.28M | $ 273.0K |
| 1995 | $ 9.39M | $ -1.36M | $ -2.27M | $ 4.20M | $ 1.30M |
| 1994 | $ 5.60M | N/A | $ -302.8K | $ 3.20M | $ 2.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.74 |
| Liabilities / Eq | -4.06 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/NNBP.md)
- [Charts](https://sponda.capital/en/NNBP/charts.md)
- [Compare](https://sponda.capital/en/NNBP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.